Pregnancy after a diagnosis of estrogen receptor-positive breast cancer does not affect prognosis

被引：1
|
作者：
Barton, Mary Kay
机构：
来源：
CA-A CANCER JOURNAL FOR CLINICIANS | 2013年 / 63卷 / 03期
关键词：
D O I：
10.3322/caac.21178
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：143 / 144
页数：4
相关论文
共 50 条
  • [1] Late Recurrences After Estrogen Receptor-Positive Breast Cancer
    Narod, Steven A.
    Giannakeas, Vasily
    Sopik, Victoria
    JAMA ONCOLOGY, 2020, 6 (02) : 301 - +
  • [2] Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer
    Zahavi, Tamar
    Salmon-Divon, Mali
    Salgado, Roberto
    Elkin, Michael
    Hermano, Esther
    Rubinstein, Ariel M.
    Francis, Prudence A.
    Di Leo, Angelo
    Viale, Giuseppe
    de Azambuja, Evandro
    Ameye, Lieveke
    Sotiriou, Christos
    Salmon, Asher
    Kravchenko-Balasha, Nataly
    Sonnenblick, Amir
    NPJ BREAST CANCER, 2021, 7 (01)
  • [3] Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer
    Tamar Zahavi
    Mali Salmon-Divon
    Roberto Salgado
    Michael Elkin
    Esther Hermano
    Ariel M. Rubinstein
    Prudence A. Francis
    Angelo Di Leo
    Giuseppe Viale
    Evandro de Azambuja
    Lieveke Ameye
    Christos Sotiriou
    Asher Salmon
    Nataly Kravchenko-Balasha
    Amir Sonnenblick
    npj Breast Cancer, 7
  • [4] Treatment of Estrogen Receptor-Positive Breast Cancer
    Lumachi, F.
    Brunello, A.
    Maruzzo, M.
    Basso, U.
    Basso, S. M. M.
    CURRENT MEDICINAL CHEMISTRY, 2013, 20 (05) : 596 - 604
  • [5] Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer
    Bostner, Josefine
    Alayev, Anya
    Berman, Adi Y.
    Fornander, Tommy
    Nordenskjold, Bo
    Holz, Marina K.
    Stal, Olle
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (01) : 17 - 27
  • [6] Estrogen Receptor-Positive Breast Cancer in Japanese Women: Trends in Incidence, Characteristics and Prognosis
    Yamashita, H.
    Iwase, H.
    Toyama, T.
    Takahashi, S.
    Sugiura, H.
    Yoshimoto, N.
    Endo, Y.
    Kobayashi, S.
    CANCER RESEARCH, 2010, 70
  • [7] MiR-187 is a marker of poor prognosis in estrogen receptor-positive breast cancer
    Mulrane, Laoighse
    Madden, Stephen
    Brennan, Donal J.
    Mcgee, Sharon F.
    Jirstrom, Karin
    van't Veer, Laura
    Bernards, Rene
    Higgins, Des
    Gallagher, William M.
    O'Connor, Darran P.
    CANCER RESEARCH, 2010, 70
  • [8] Bisphosphonate Use After Estrogen Receptor-Positive Breast Cancer and Risk of Contralateral Breast Cancer
    Monsees, Genevieve M.
    Malone, Kathleen E.
    Tang, Mei-Tzu C.
    Newcomb, Polly A.
    Li, Christopher I.
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (23) : 1752 - 1760
  • [9] Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer
    Josefine Bostner
    Anya Alayev
    Adi Y. Berman
    Tommy Fornander
    Bo Nordenskjöld
    Marina K. Holz
    Olle Stål
    Breast Cancer Research and Treatment, 2018, 168 : 17 - 27
  • [10] Estrogen receptor-positive breast cancer in Japanese women: trends in incidence, characteristics, and prognosis
    Yamashita, H.
    Iwase, H.
    Toyama, T.
    Takahashi, S.
    Sugiura, H.
    Yoshimoto, N.
    Endo, Y.
    Fujii, Y.
    Kobayashi, S.
    ANNALS OF ONCOLOGY, 2011, 22 (06) : 1318 - 1325
12345